Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: The GLISTEN study - A randomised controlled trial

Peter A. Frith, Philip J. Thompson, Rajeev Ratnavadivel, Catherina L. Chang, Peter Bremner, Peter Day, Christina Frenzel, Nicol Kurstjens, Glisten Study Group

Research output: Contribution to journalArticlepeer-review

66 Citations (Scopus)

Fingerprint Dive into the research topics of 'Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: The GLISTEN study - A randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences